Global Anaesthesia Drugs Market is expected to reach US$ XX Mn by 2026 from US$ XX Mn in 2019, at a CAGR of 3.8% during the forecast period.
Global Anaesthesia Drugs Market Overview:
Anaesthesia is a medical procedure that allows patients to be pain-free during surgery. Anaesthetics are administered by injection, inhalation, topical lotion, spray, eye drops, or a skin patch, depending on the type of pain relief required.
Global Anaesthesia Drugs Market Dynamics:
Increasing cases of surgical procedures around the globe are the major driving factor for market growth.
Various surgical procedures such as plastic surgeries, cosmetic surgeries, dental surgeries and cardiovascular surgeries are being carried out at a higher rate across the globe. This proves to be the primary factor for market growth. Along with this, new drug approvals and ongoing development in the research field encourage market growth. According to a study published by the International Society of Aesthetic Plastic Surgery, the number of plastic operations performed worldwide increased by 7.4% in 2019 compared to 2018.
The rising prevalence of cancer, cardiovascular diseases and road accident cases boosts the market growth. The WHO's Global Status Report on Road Safety 2018 states that there were 1.35 million road accidents in 2018, with 64 deaths per 100,000 vehicles. The American Heart Association's 2018 Heart Disease and Stroke Statistics state that about 92.1 million people in the United States suffer from cardiovascular diseases or stroke-related complications. This factor raises the demand for general surgery along with anaesthesia market.
The demand for anaesthetics in surgical procedures is expected to increase owing to the improvement in drug delivery technologies. DepoFoam technology employs a novel method of delivering bupivacaine and is extremely effective in the treatment of post-operative pain. The increasing geriatric population and rising demand for anaesthesia in labour patients are expected to contribute to the market growth.
However, drug side effects, regulatory concerns, a shortage of health care facilities in developing countries, and a scarcity of qualified anaesthetic doctors are likely to limit the market's growth.
The report has profiled seventeen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.
Global Anaesthesia Drugs Market Segment Analysis:
The Global Anaesthesia Drugs Market is segmented on the basis of Type, Drug Type and Route of Administration.
Based on Drug Type, the Propofol segment is expected to dominate the global market during the forecast period. It is estimated to grow at a CAGR of 4.5% during the forecast period. Propofol is a sedative used in critical care and is one of the most widely used general anaesthetics in surgeries. It's used to start and maintain procedural sedation, general anaesthesia, and other types of anaesthesia.
This drug has been used for a variety of surgical procedures that involve anaesthesia. Neon Laboratories Limited, Bharat Serums and Vaccines Limited, and Fresenius Kabi are some of the companies that make propofol injections.
Based on Type, the Local Anaesthesia segment is expected to account for the largest market share during the forecast period. The segment is expected to grow at a CAGR of 3.2% during the forecast years. A small area of the body is numbed with local anaesthesia. It may be applied to a tooth that needs to be extracted or a small area around a wound that needs to be stitched. With Local Anaesthesia patients stay conscious and comfortable.
To know about the Research Methodology :- Request Free Sample Report
Global Anaesthesia Drugs Market Regional Insights:
North America dominates the global market of Anaesthesia drugs.
North America is expected to continue its dominance throughout the forecast period. Recently, the region faced a shortage of some anaesthetics drugs during the emergency of the COVID-19 pandemic. To overcome this, many manufactures have boosted their production for these anaesthetics.
This factor is contributing to the market growth. Furthermore, the growing number of surgeries, a geriatric population that is prone to chronic conditions, and advances in anaesthesia technology are driving this market in the region. The American Society of Plastic Surgeons (ASPS) states that almost 1.8 million cosmetic surgical procedures and 16.3 million cosmetic minimally-invasive procedures were conducted in the United States in 2019.
The report also helps in understanding the Global Anaesthesia Drugs Market dynamics, structure by analyzing the market segments and project the Global Anaesthesia Drugs Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Anaesthesia Drugs Market make the report investor’s guide.
Global Anaesthesia Drugs Market, Key Development:
• BYFAVO (remimazolam) was approved by the United States Food and Drug Administration (FDA) in July 2020 for injection, induction, and maintenance of procedural sedation in adults undergoing procedures lasting less than 30 minutes. This drug is manufactured by Acacia Pharma Plc.
• SunGen Pharma collaborated with Athenex Pharmaceuticals in June 2019 to launch Bivalirudin to be used as an injection in the near future.
For more information visit@
https://www.maximizemarketresearch.com/market-report/global-anaesthesia-drugs-market/100028/
rnGlobal Anaesthesia Drugs Market Scope: Inquire before buying
Global Anaesthesia Drugs Market, by Region
• North Americarn• Europern• South Americarn• MEArn• APAC
Global Anaesthesia Drugs Market, Key Players
• Abbott Laboratoriesrn• Astrazeneca PLCrn• Baxter International Inc.
• Hospira, Inc.
• F. Hoffmann-La Roche Ltd.
• Hikma Pharmaceuticals PLCrn• AbbVie Inc.
• Fresenius Se & Co. Kgaarn• Pfizer Inc.
• Piramal Enterprises Limitedrn• Par Pharmaceuticalrn• Teva Pharmaceuticalsrn• Novartis AGrn• GlaxoSmithKline plcrn• Gilead Sciences, Inc.
• Sanofirn• Heritage Pharmaceuticals Inc.
This report submitted by Maximize market Research CompanyrnCustomization of the report:rnMaximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.rnAbout Maximize Market Research:rnMaximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.